annual D&A:
$80.41M-$4.45M(-5.24%)Summary
- As of today (September 15, 2025), SUPN annual depreciation & amortization is $80.41 million, with the most recent change of -$4.45 million (-5.24%) on December 31, 2024.
- During the last 3 years, SUPN annual D&A has risen by +$47.82 million (+146.71%).
- SUPN annual D&A is now -6.00% below its all-time high of $85.54 million, reached on December 31, 2022.
Performance
SUPN Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$21.36M+$975.00K(+4.78%)Summary
- As of today (September 15, 2025), SUPN quarterly depreciation & amortization is $21.36 million, with the most recent change of +$975.00 thousand (+4.78%) on June 30, 2025.
- Over the past year, SUPN quarterly D&A has increased by +$640.00 thousand (+3.09%).
- SUPN quarterly D&A is now -2.28% below its all-time high of $21.86 million, reached on September 30, 2023.
Performance
SUPN quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$80.69M+$640.00K(+0.80%)Summary
- As of today (September 15, 2025), SUPN TTM depreciation & amortization is $80.69 million, with the most recent change of +$640.00 thousand (+0.80%) on June 30, 2025.
- Over the past year, SUPN TTM D&A has dropped by -$4.31 million (-5.07%).
- SUPN TTM D&A is now -5.68% below its all-time high of $85.54 million, reached on December 31, 2022.
Performance
SUPN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
SUPN Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.2% | +3.1% | -5.1% |
| 3 y3 years | +146.7% | -0.9% | +29.5% |
| 5 y5 years | +1107.6% | +413.0% | +544.2% |
SUPN Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.0% | +146.7% | -2.3% | +13.3% | -5.7% | +29.5% |
| 5 y | 5-year | -6.0% | +1107.6% | -2.3% | +631.2% | -5.7% | +544.2% |
| alltime | all time | -6.0% | >+9999.0% | -2.3% | >+9999.0% | -5.7% | >+9999.0% |
SUPN Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $21.36M(+4.8%) | $80.69M(+0.8%) |
| Mar 2025 | - | $20.38M(+8.2%) | $80.05M(-0.5%) |
| Dec 2024 | $80.41M(-5.2%) | $18.84M(-6.3%) | $80.41M(-3.4%) |
| Sep 2024 | - | $20.10M(-3.0%) | $83.25M(-2.1%) |
| Jun 2024 | - | $20.72M(-0.1%) | $85.00M(-0.0%) |
| Mar 2024 | - | $20.75M(-4.3%) | $85.01M(+0.2%) |
| Dec 2023 | $84.86M(-0.8%) | $21.68M(-0.8%) | $84.86M(+1.0%) |
| Sep 2023 | - | $21.86M(+5.5%) | $84.03M(+0.1%) |
| Jun 2023 | - | $20.73M(+0.6%) | $83.95M(-1.0%) |
| Mar 2023 | - | $20.60M(-1.2%) | $84.78M(-0.9%) |
| Dec 2022 | $85.54M(+162.4%) | $20.85M(-4.3%) | $85.54M(+10.5%) |
| Sep 2022 | - | $21.77M(+1.0%) | $77.40M(+24.2%) |
| Jun 2022 | - | $21.56M(+0.9%) | $62.30M(+31.5%) |
| Mar 2022 | - | $21.36M(+68.1%) | $47.37M(+45.3%) |
| Dec 2021 | $32.59M(+79.7%) | $12.71M(+90.4%) | $32.59M(+42.9%) |
| Sep 2021 | - | $6.67M(+0.8%) | $22.81M(-6.8%) |
| Jun 2021 | - | $6.62M(+0.4%) | $24.47M(+11.2%) |
| Mar 2021 | - | $6.59M(+125.7%) | $22.01M(+21.3%) |
| Dec 2020 | $18.14M(+172.4%) | $2.92M(-65.0%) | $18.14M(+1.8%) |
| Sep 2020 | - | $8.33M(+100.2%) | $17.82M(+42.2%) |
| Jun 2020 | - | $4.16M(+52.9%) | $12.53M(+20.6%) |
| Mar 2020 | - | $2.72M(+4.9%) | $10.39M(+1.6%) |
| Dec 2019 | $6.66M(-5.7%) | $2.60M(-14.7%) | $10.22M(+9.7%) |
| Sep 2019 | - | $3.04M(+50.2%) | $9.32M(+14.2%) |
| Jun 2019 | - | $2.03M(-20.8%) | $8.16M(+3.1%) |
| Mar 2019 | - | $2.56M(+51.2%) | $7.91M(+12.0%) |
| Dec 2018 | $7.06M(-13.1%) | $1.69M(-10.2%) | $7.06M(+0.3%) |
| Sep 2018 | - | $1.88M(+5.8%) | $7.04M(-26.2%) |
| Jun 2018 | - | $1.78M(+4.3%) | $9.54M(+4.8%) |
| Mar 2018 | - | $1.71M(+2.2%) | $9.10M(+11.9%) |
| Dec 2017 | $8.13M | $1.67M(-61.9%) | $8.13M(+14.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $4.38M(+226.0%) | $7.13M(+111.9%) |
| Jun 2017 | - | $1.34M(+81.2%) | $3.37M(+24.2%) |
| Mar 2017 | - | $741.00K(+10.4%) | $2.71M(+13.0%) |
| Dec 2016 | $2.40M(+160.5%) | $671.00K(+9.8%) | $2.40M(+20.1%) |
| Sep 2016 | - | $611.00K(-11.2%) | $2.00M(+24.3%) |
| Jun 2016 | - | $688.00K(+60.4%) | $1.61M(+41.5%) |
| Mar 2016 | - | $429.00K(+58.9%) | $1.14M(+23.3%) |
| Dec 2015 | $921.00K(-0.8%) | $270.00K(+22.7%) | $921.00K(+4.9%) |
| Sep 2015 | - | $220.00K(+1.4%) | $878.00K(-2.3%) |
| Jun 2015 | - | $217.00K(+1.4%) | $899.00K(-1.7%) |
| Mar 2015 | - | $214.00K(-5.7%) | $915.00K(-1.4%) |
| Dec 2014 | $928.00K(+25.1%) | $227.00K(-5.8%) | $928.00K(+1.2%) |
| Sep 2014 | - | $241.00K(+3.4%) | $917.00K(+4.7%) |
| Jun 2014 | - | $233.00K(+2.6%) | $876.00K(+8.6%) |
| Mar 2014 | - | $227.00K(+5.1%) | $807.00K(+8.8%) |
| Dec 2013 | $742.00K(-14.8%) | $216.00K(+8.0%) | $742.00K(-0.7%) |
| Sep 2013 | - | $200.00K(+22.0%) | $747.00K(-1.6%) |
| Jun 2013 | - | $164.00K(+1.2%) | $759.00K(-6.2%) |
| Mar 2013 | - | $162.00K(-26.7%) | $809.00K(-7.1%) |
| Dec 2012 | $871.00K(-0.9%) | $221.00K(+4.2%) | $871.00K(-0.8%) |
| Sep 2012 | - | $212.00K(-0.9%) | $878.00K(-1.3%) |
| Jun 2012 | - | $214.00K(-4.5%) | $890.00K(-0.6%) |
| Mar 2012 | - | $224.00K(-1.8%) | $895.00K(+1.8%) |
| Dec 2011 | $879.00K(-26.0%) | $228.00K(+1.8%) | $879.00K(+35.0%) |
| Sep 2011 | - | $224.00K(+2.3%) | $651.00K(+52.5%) |
| Jun 2011 | - | $219.00K(+5.3%) | $427.00K(+105.3%) |
| Mar 2011 | - | $208.00K | $208.00K |
| Dec 2010 | $1.19M(+10.8%) | - | - |
| Dec 2009 | $1.07M(-3.9%) | - | - |
| Dec 2008 | $1.11M(+19.6%) | - | - |
| Dec 2007 | $932.20K | - | - |
FAQ
- What is Supernus Pharmaceuticals, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. annual D&A year-on-year change?
- What is Supernus Pharmaceuticals, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. quarterly D&A year-on-year change?
- What is Supernus Pharmaceuticals, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. TTM D&A year-on-year change?
What is Supernus Pharmaceuticals, Inc. annual depreciation & amortization?
The current annual D&A of SUPN is $80.41M
What is the all time high annual D&A for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high annual depreciation & amortization is $85.54M
What is Supernus Pharmaceuticals, Inc. annual D&A year-on-year change?
Over the past year, SUPN annual depreciation & amortization has changed by -$4.45M (-5.24%)
What is Supernus Pharmaceuticals, Inc. quarterly depreciation & amortization?
The current quarterly D&A of SUPN is $21.36M
What is the all time high quarterly D&A for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high quarterly depreciation & amortization is $21.86M
What is Supernus Pharmaceuticals, Inc. quarterly D&A year-on-year change?
Over the past year, SUPN quarterly depreciation & amortization has changed by +$640.00K (+3.09%)
What is Supernus Pharmaceuticals, Inc. TTM depreciation & amortization?
The current TTM D&A of SUPN is $80.69M
What is the all time high TTM D&A for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high TTM depreciation & amortization is $85.54M
What is Supernus Pharmaceuticals, Inc. TTM D&A year-on-year change?
Over the past year, SUPN TTM depreciation & amortization has changed by -$4.31M (-5.07%)